Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China.
- Author:
Xi Qin HAN
1
,
2
,
3
;
Yu PANG
1
;
Yan MA
1
;
Yu Hong LIU
1
;
Ru GUO
1
;
Wei SHU
1
;
Xue Rui HUANG
1
;
Qi Ping GE
1
;
Jian DU
1
;
Wei Wei GAO
1
;
Author Information
- Publication Type:Journal Article
- Keywords: Adverse drug reactions; Anti-TB medications; Tuberculosis; Tuberculosis treatment
- MeSH: Adolescent; Adult; Antitubercular Agents; adverse effects; therapeutic use; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Tuberculosis, Pulmonary; drug therapy; epidemiology; Young Adult
- From: Biomedical and Environmental Sciences 2017;30(2):139-142
- CountryChina
- Language:English
- Abstract: We assessed the incidence of adverse drug reactions (ADRs) with anti-TB medications and evaluated the risk factors for developing ADRs in previously treated tuberculosis patients in China. All patients received the first-line anti-TB regimen (2HREZS/6HRE) as recommended by the national guidelines. Clinical and laboratory evaluations were performed once a month. Out of the 354 participants, 262 (74.0%) experienced ADRs such as hyperuricemia (65.0%, 230/354), hepatotoxicity (6.2%, 22/354) and hearing disturbances (4.8%, 17/354). ADRs were significantly associated with diabetes mellitus [OR (95% CI): 15.5 (2.07-115.87)]; however, weight more than 50 kg [OR (95% CI): 0.41 (0.22-0.85)] was a protective factor for occurrence of ADRs. Hyperuricemia is the most common adverse event but, most patients with hyperuricemia showed increased tolerance for high uric acid levels. Low body weight and diabetes mellitus increased the risk of the occurrence of ADRs during anti-TB treatment.
